Bioscience

Sygnis Pharma Buys TGen Spin-out Amnestix for $6.3M

June 9, 2008

By Flinn Foundation

[Source: a GenomeWeb staff reporter ] – German drug developer Sygnis Pharma has bought Amnestix, a spin-out from the Translational Genomics Research Institute, for